Digital products for companies built on evidence.
We are a life sciences digital agency building websites, portals and digital platforms for diagnostics, laboratories, medtech and research companies across Europe — including the operational tools that sit behind the public site and actually run part of the business.
In life sciences the website is often the smallest part of the job. The value tends to sit in what it connects to: catalogues, instruments, laboratories, distributors and the systems that track them.
A life sciences digital agency brief rarely stops at a corporate site. It includes a technical catalogue, distributor access to documentation, a lead flow feeding the CRM, and often a tool a department already runs badly in spreadsheets.
Corporate websites, technical catalogues, partner and distributor portals, custom operational platforms, CRM and system integrations, multilingual rollouts and ongoing maintenance of the estate.
Regulated medical device software, LIMS products and anything requiring clinical validation. We build the digital layer around those systems rather than the systems themselves.
Platforms that departments use daily, with the maintenance relationship to prove it. A life sciences digital agency lives or dies on catalogue volume, document control and how many markets the system can hold at once.
A diagnostics company selling through distributors and a clinical laboratory selling tests directly need almost nothing in common. Life sciences digital work starts from that operation, not from a template.
What comes up when the brief is bigger than a website.
It is one system, usually delivered in sequence. Trying to launch all three together is where budgets get lost. We define the shared foundation — data model, access levels, integrations — and then release the pieces in an order where each one is useful on its own.
Yes, and the routing is usually more valuable than the integration itself. We tag enquiries by type at the point of submission, so a catalogue request, a technical consultation and a distributor application land in the CRM already separated and assigned, instead of arriving as one undifferentiated inbox your team has to sort manually.
Usually with a private area holding the documentation and assets each market is cleared to use, plus a public network page that gives buyers confidence the coverage is real. The access rules get defined at architecture stage, because retrofitting them is painful.
That is a normal starting point, and it is usually the first real task. Restructuring the product data — deciding what the fields are, which are mandatory, and who owns them — often takes longer than building the site, and skipping it guarantees the same problem a year later.
Yes, specifically on the digital layer around the product rather than the product itself. That covers catalogues, technical documentation, lead generation and distributor support — the parts that help buyers evaluate and purchase. We do not build or validate the regulated software or instrument firmware; that stays with your engineering team.
If the architecture was built for it, adding a market becomes content and configuration work rather than a development project. That is the entire point of defining country availability and language handling early, instead of treating the second or third language as an afterthought bolted on once the first market is live.
A technical catalogue, a distributor portal, an operational tool or all three connected. Tell us the context and we will tell you how we would approach the life sciences digital work.